GSK, Johns Hopkins Medical Institutions, Mass General Cancer Center join global network to accelerate discoveries in COVID-19, oncology, immuno-oncology and neurology PLEASANTON, Calif., June 17, 2020 ...
Combining tissue profiling with whole transcriptome spatial analysis and high-plex protein co-detection enables a deeper, more holistic understanding of tissue organization "The continued expansion of ...
Cure51 plans to analyze more than 1,000 tumor samples from exceptional cancer survivors Working alongside more than 50 medical institutions, Cure51 intends to collect and analyze tumor tissues from ...
Spontaneous Russell (left) is a Staff Product Manager for Visium Spatial Gene Expression technologies from 10x Genomics (CA, USA). She has spent the last 20 years leading product development and ...
10x Genomics Inc. began distribution of its new Visium Spatial Gene Expression for FFPE (formalin-fixed and paraffin-embedded) assay in the U.S., giving researchers access to whole transcriptome ...
After growing its Xenium In Situ single-cell spatial imaging platform into its third successful technology family last year, 10x Genomics has no plans for launching a fourth platform in 2024—but will ...
PARIS and PLEASANTON, Calif., Oct. 31, 2024 /PRNewswire/ -- French TechBio startup Cure51 and 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today that Cure51 ...
PLEASANTON, Calif., Feb. 23, 2025 /PRNewswire/ — At the Advances in Genome Biology and Technology (AGBT) General Meeting, 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, ...
10x Genomics Inc. began distribution of its new Visium Spatial Gene Expression for FFPE (formalin-fixed and paraffin-embedded) assay in the U.S., giving researchers access to whole transcriptome ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback